BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 13427602)

  • 1. [Personal experience with 2-methyl-2-propyl-1, 3-propanediol dicarbamate in a group of allergic patients].
    GARAT B; BERRUEZO JJ; ORCIUELI L
    Dia Med; 1957 Mar; 29(10):234; passim. PubMed ID: 13427602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methyl-propyl-propanediol dicarbamate (meprobamate) in dermatology].
    KAMINSKY A; KAPLAN A; SEVINSKY B
    Minerva Med; 1956 Nov; 47(88):1478-80. PubMed ID: 13387292
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of 2-methyl-2-N-propyl-1, 3-propanediol dicarbamate in psychiatry].
    FLORIS V; RAMBELLI L
    Minerva Med; 1956 Nov; 47(88):1455-7. PubMed ID: 13387286
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of effect of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate) on psychiatric states.
    BORRUS JC
    J Am Med Assoc; 1955 Apr; 157(18):1596-8. PubMed ID: 14367013
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical study of a new tranquilizing drug; use of miltown (2-methyl-2-n-propyl-1,3-propanediol dicarbamate).
    SELLING LS
    J Am Med Assoc; 1955 Apr; 157(18):1594-6. PubMed ID: 14367012
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system.
    HENDLEY CD; LYNES TE; BERGER FM
    Proc Soc Exp Biol Med; 1954 Dec; 87(3):608-10. PubMed ID: 13237321
    [No Abstract]   [Full Text] [Related]  

  • 7. [TRANSPLACENTAL PASSAGE OF 2-METHYL 2N-PROPYL 1-3 PROPANDIOL DICARBAMATE].
    PALMIERI A
    Arch Ostet Ginecol; 1964; 69():552-8. PubMed ID: 14253212
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent.
    BERGER FM
    J Pharmacol Exp Ther; 1954 Dec; 112(4):413-23. PubMed ID: 13222235
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxic reaction to 2-methyl-2-n-propyl-1, 3, propanediol dicarbamate (miltown and equanil).
    HOLOUBEK JE; THOMAS OC; SEGURA J
    Ann Intern Med; 1957 May; 46(5):1002-4. PubMed ID: 13411911
    [No Abstract]   [Full Text] [Related]  

  • 10. Central depressant and anticonvulsant activity of compounds isomeric with 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (miltown).
    BERGER FM; HENDLEY CD; LUDWIG BJ; LYNES TE
    J Pharmacol Exp Ther; 1956 Mar; 116(3):337-42. PubMed ID: 13307395
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonthrombocytopenic purpura due to Miltown (2-methyl-2-N-propyl-1,3 propanediol dicarbamate).
    Carmel WJ; Dannenberg T
    N Engl J Med; 1956 Oct; 255(16):770-1. PubMed ID: 13369712
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the absorption of acetylsalicylic acid and salicylates in association with N-isopropyl-2-methyl-2-propyl-1,3-propanediol dicarbamate (Carisoprodol)].
    CARPI C; PARENTI MA; MANDELLI V
    Farmaco Prat; 1963 Apr; 18():199-205. PubMed ID: 14040581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of administration of 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate (meprobamate) in mental disorders].
    IMBERCIADORI S; MANGANARO D
    Minerva Med; 1956 Dec; 47(102):2181-4. PubMed ID: 13399942
    [No Abstract]   [Full Text] [Related]  

  • 14. Soma: normal hematopoletic response to hematinics during the administration of N-isopropyl-2-methyl-2-propyl-1, 3-propanediol dicarbamate.
    BARNARD RD; BILLOW BW
    Harlem Hosp Bull (N Y); 1960 Mar; 1():68-71. PubMed ID: 13796855
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate).
    MACCAGNANI G
    Rass Neuropsichiatr; 1957; 11(3-4):145-71. PubMed ID: 13506106
    [No Abstract]   [Full Text] [Related]  

  • 16. THIO ANALOGS OF CARISOPRODOL (N-ISOPROPYL-2-METHYL-2-PROPYL-1,3-PROPANEDIOL DICARBAMATE).
    LEAFFER MA; SKINNER WA
    J Med Chem; 1965 Mar; 8():208-12. PubMed ID: 14332662
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinical evaluation of miltown (2 methyl-2-N-propyl-1, 3 propanediol dicarbamate).
    WEINSTEIN GJ
    N Y State J Med; 1957 Jun; 57(12):2060. PubMed ID: 13441048
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of a new drug with sedative action: 2-methyl-2-n-propyl-1, 3-propanediol dicarbamate].
    RIGOTTI S
    Minerva Med; 1956 Dec; 47(102):2178-81. PubMed ID: 13399941
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trials of a new hypotensive drug: 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate].
    POZZI LL; CAGNONI M
    Gazz Med Ital; 1963 Jan; 122():1-7. PubMed ID: 13985873
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the hypotensive effect of 2-methyl-2-sec-butyl-1,3-propanediol dicarbamate (mebutamate)].
    MARANGONI R; MELLONI GF
    Atti Soc Ital Cardiol; 1962 Jun 1-3; 2():269-71. PubMed ID: 13932756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.